Literature DB >> 10203749

Towards gene therapy of diabetes mellitus.

F Levine1, G Leibowitz.   

Abstract

A definitive treatment for diabetes mellitus will be one that maintains a normal blood glucose concentration in the face of fluctuating dietary intake. To accomplish this, there must be mechanisms to sense the amount of blood glucose coupled to rapid release of the right amount of insulin. While mechanical devices to accomplish this are being developed, ultimately the best approach is likely to be based on genetic modification of cells. These could be pancreatic beta-cells, which are the only cells that produce insulin, or other cells that are involved in the pathogenesis of diabetes. Although definitive treatment of diabetes using genetically modified cells is a long-term goal, much progress is being made. This review discusses various approaches to modifying cells genetically, both in vitro and in vivo, for the treatment of diabetes.

Entities:  

Mesh:

Year:  1999        PMID: 10203749     DOI: 10.1016/s1357-4310(98)01425-7

Source DB:  PubMed          Journal:  Mol Med Today        ISSN: 1357-4310


  9 in total

1.  [Therapy of diabetes mellitus. Pancreas transplantation, islet transplantation, stem cell and gene therapy].

Authors:  C Dieterle; M D Brendel; J Seissler; M Eckhard; R G Bretzel; R Landgraf
Journal:  Internist (Berl)       Date:  2006-05       Impact factor: 0.743

2.  Protamine sulfate enhances the transduction efficiency of recombinant adeno-associated virus-mediated gene delivery.

Authors:  Y W Yang; Y C Hsieh
Journal:  Pharm Res       Date:  2001-07       Impact factor: 4.200

3.  Remission of diabetes by insulin gene therapy using a hepatocyte-specific and glucose-responsive synthetic promoter.

Authors:  Jaeseok Han; Brienne McLane; Eung-Hwi Kim; Ji-Won Yoon; Hee-Sook Jun
Journal:  Mol Ther       Date:  2010-11-30       Impact factor: 11.454

4.  Engineering Vero cells to secrete human insulin.

Authors:  Lorraine O'Driscoll; Patrick Gammell; Martin Clynes
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-03       Impact factor: 2.416

5.  Glucose-modulated transgene expression via recombinant adeno-associated virus.

Authors:  Ya-Wun Yang; Yuan-Chiao Hsieh; Chih-Kai Chao
Journal:  Pharm Res       Date:  2002-07       Impact factor: 4.200

6.  Coupling of glucose response element from L-type pyruvate kinase and G6Pase promoter enhances glucose responsive activity in hepatoma cells.

Authors:  Michael S Lan; Hong-Wei Wang; James Chong; Mary B Breslin
Journal:  Mol Cell Biochem       Date:  2006-12-08       Impact factor: 3.842

Review 7.  Current status and prospects for gene and cell therapeutics for type 1 diabetes mellitus.

Authors:  Nick Giannoukakis; Massimo Trucco
Journal:  Rev Endocr Metab Disord       Date:  2003-12       Impact factor: 9.306

8.  Diabetes mellitus: new challenges and innovative therapies.

Authors:  Cristina M Sena; Carla F Bento; Paulo Pereira; Raquel Seiça
Journal:  EPMA J       Date:  2010-03-13       Impact factor: 6.543

9.  Treatment of diabetic rats with encapsulated islets.

Authors:  Ian R Sweet; Ofer Yanay; Lanaya Waldron; Merle Gilbert; Jessica M Fuller; Terry Tupling; Ake Lernmark; William R A Osborne
Journal:  J Cell Mol Med       Date:  2008-03-28       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.